Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

Latest News

President says Egypt 'scored a goal' with Israel gas deal

Feb 21, 2018

CAIRO — The Egyptian president declared on Wednesday that his country "scored a goal" by signing a $15 billion deal with an Israeli company to supply natural gas that will help turn Egypt into a regional energy hub. President Abdel Fatah el-Sissi's televised remarks were the first high-level comments on the deal that fueled controversy on social media. The project "has a lot of advantages for us (Egyptians). And I want people to be reassured," el-Sissi said. The Egyptian government was not directly involved in the deal, however, but "provided several things to ... achieve this deal," he said. "By...

State witness turning point in Netanyahu corruption case

Feb 21, 2018

JERUSALEM — Now that one of Benjamin Netanyahu's closest confidants has turned state witness, according to Israeli media reports Wednesday, it may mark a turning point for the beleaguered prime minister facing a slew of corruption allegations that could topple him from power. The testimony by Shlomo Filber, a long-time Netanyahu aide, is the latest in a dizzying series of developments and scandals that have engulfed the prime minister, his family and his inner circle. Police would not confirm whether Filber would testify against Netanyahu, but all the major Israeli media outlets said a deal to do so had been...

Bahrain sentences prominent activist to 5 years in prison

Feb 21, 2018

DUBAI, United Arab Emirates — A prominent human rights activist in Bahrain was sentenced Wednesday to five years in prison over tweets alleging prison torture in his country and misconduct in Saudi Arabia's war in Yemen, despite wide international criticism of his trial. Nabeel Rajab's sentencing marks the latest chapter in a yearslong crackdown on dissent in Bahrain, a tiny island kingdom off the coast of Saudi Arabia that's home to the U.S. Navy's 5th Fleet. He's already serving a two-year sentence handed down in July over television interviews he gave that included criticism of Bahrain. Rajab has been hospitalized...

Turkey to develop unmanned tanks, president says

Feb 21, 2018

ANKARA, Turkey — Turkey's president says the country will develop unmanned tanks to minimize risks to soldiers in combat. Recep Tayyip Erdogan announced the plan Wednesday during a speech delivered at a conference on Turkey's five-year development plan. His comments came as Turkey's military is carrying out a cross-border offensive in Syria to clear a border enclave of Syrian Kurdish rebels. Erdogan said: "We need to be able to manufacture unmanned tanks and we will do this ... We are becoming a country that is catching this technology." The Turkish leader said that U.S. refusal to provide Turkey with drones...

Netanyahu confidant identified as scandals mount

Feb 21, 2018

JERUSALEM — Prime Minister Benjamin Netanyahu, already reeling from a damaging police report into alleged corruption, faced yet another scandal on Tuesday — with allegations that a longtime confidant attempted to bribe a judge in exchange for dropping a corruption case against the Israeli leader's wife. Netanyahu quickly denounced the allegations. But they presented an embarrassing new headache for him as a growing list of members of his inner circle gets swept up in scandals. The latest case surrounds Nir Hefetz, a longtime media adviser to Netanyahu and his family. Hefetz is suspected of suggesting, through a middleman, to Judge...

About Us

Get a quick look at what’s happening in the world today with in-depth analysis on international news, politics, business and technology, only in Central News Today.

Contact us: sales@centralnewstoday.com

Subscribe Now!